Start

Contract for the Provision for the Manufacture of Vaccine Antigen

Frist:16 Oct 2025, 00:00 GMT+1

Ausschreibungsinformationen

TED EU

Dublin, Ireland

Art
16
Verfahren
open
Referenznummer
634422-2025
Geschätzter Wert
100,000 EUR
CPV
33651600

UCD has developed a series of bacterial antigens which have proven effective in proof-of-concept studies and which the aim is to further develop and translate to humans. The lead target antigen is 22 kDa cytosolic bacter

Alle Ausschreibungsinformationen anzeigen

Dokumente

Alle wichtigen Termine anzeigen